Proteolysis, the breakdown of proteins into smaller peptides or individual amino acids, happens in multiple locations throughout the body, from inside individual cells to the digestive tract to the bloodstream. Your body breaks down and replaces 300 to 400 grams of protein every day, far more than the 50 to 80 grams most people eat. That constant recycling takes place across several distinct biological compartments, each with its own enzymes and purposes.
The Digestive Tract
The most familiar site of proteolysis is the gastrointestinal system, where dietary protein gets broken down so your body can absorb it. This starts in the stomach. Specialized cells in the stomach lining called chief cells release an inactive enzyme called pepsinogen. When pepsinogen meets the hydrochloric acid in gastric juice, it converts into its active form, pepsin. Pepsin is the principal enzyme for protein digestion in the stomach, chopping dietary proteins into smaller peptide fragments.
Once that partially digested material moves into the duodenum (the first stretch of the small intestine), the rising pH above 6 deactivates pepsin. Protein digestion doesn’t stop, though. The pancreas releases a fresh set of enzymes, including trypsin, chymotrypsin, elastase, and carboxypeptidase, which continue breaking peptides down into amino acids small enough for absorption through the intestinal wall.
The Proteasome in the Cytoplasm and Nucleus
Inside your cells, the main protein-demolition machine is the 26S proteasome, a large barrel-shaped complex found throughout the cytoplasm and nucleus of every cell. The proteasome doesn’t destroy proteins randomly. It relies on a tagging system: proteins marked for destruction get a chain of a small molecule called ubiquitin attached to them. This ubiquitin tag acts like a molecular shipping label that tells the proteasome, “this one needs to go.”
The process works in steps. First, the proteasome’s outer cap recognizes the ubiquitin chain on a target protein. Specialized components then strip off the ubiquitin tags (which get recycled) and unfold the protein into a linear chain. That unfolded strand is threaded through a narrow central pore into the proteasome’s core, where cutting enzymes chop it into small peptide fragments. The pore is too narrow for folded proteins to pass through accidentally, which prevents the proteasome from destroying healthy proteins that wander too close. The entire process requires energy from ATP.
This system controls everything from cell division timing to immune responses, by selectively destroying regulatory proteins when they’re no longer needed.
Lysosomes
Lysosomes are membrane-enclosed compartments inside cells that function as recycling centers. They maintain a highly acidic interior, with a pH around 4 to 5, and contain a family of protein-cutting enzymes called cathepsins. There are roughly 15 known cathepsins, falling into three categories: cysteine cathepsins (the largest group, with 11 members), aspartic cathepsins, and serine cathepsins. All of them work best in the acidic lysosomal environment.
Lysosomes handle bulk recycling. They digest proteins delivered through autophagy (when a cell packages its own worn-out components for disposal) and through endocytosis (when material from outside the cell gets internalized). Some cathepsins can also function outside lysosomes at neutral pH, though at reduced efficiency. Cathepsin D, for instance, works optimally at pH 4 but retains some activity even at a normal cellular pH of 7.4.
The Endoplasmic Reticulum Quality Control System
The endoplasmic reticulum (ER) is where cells manufacture many of their proteins, folding them into the correct three-dimensional shapes. Not every protein folds correctly, and misfolded proteins can be toxic. The cell handles this through a process called ER-associated degradation, or ERAD.
Misfolded proteins in the ER are recognized by quality-control machinery and threaded back through the ER membrane into the cytoplasm, a process called retrotranslocation. A channel protein called Hrd1 forms the pore through which these defective proteins are pushed. Once the misfolded protein emerges on the cytoplasmic side, it gets tagged with ubiquitin chains. A molecular motor then uses ATP energy to progressively pull the protein fully out of the membrane. From there, the ubiquitin tag is trimmed, and the protein is handed off to the proteasome for final destruction. So the ER identifies the problem, but the actual proteolysis still happens in the cytoplasm via the proteasome.
Mitochondria
Mitochondria, the energy-producing compartments in cells, run their own internal quality control. The mitochondrial matrix contains dedicated proteases, most notably LON and ClpXP, that degrade damaged or misfolded proteins before they can form toxic clumps. These proteases are structurally similar to bacterial enzymes, which makes sense given that mitochondria evolved from ancient bacteria. Beyond simple cleanup, LON and ClpXP also regulate mitochondrial gene expression and help maintain the respiratory chain complexes that produce cellular energy.
The Extracellular Space
Proteolysis isn’t confined to the inside of cells. In the spaces between cells, a family of enzymes called matrix metalloproteinases (MMPs) break down structural proteins in the extracellular matrix, the scaffolding that holds tissues together. MMP1, for example, cuts specific bonds in collagen, the most abundant protein in connective tissue. MMP13 degrades type II collagen and a cartilage component called aggrecan.
This extracellular proteolysis serves several purposes. It creates physical space for cells to migrate during wound healing or development. It releases biologically active protein fragments that can serve as signaling molecules. And it remodels tissue architecture, which is essential during growth, repair, and immune responses. MMPs don’t just target structural proteins. They also process growth factors, cell-adhesion molecules, and immune signaling molecules, making them key regulators of tissue behavior.
The Bloodstream
Blood clotting is one of the most dramatic examples of proteolysis outside cells. The coagulation cascade is a chain reaction in which inactive enzyme precursors (called zymogens) are activated one after another through limited proteolysis, meaning each enzyme makes just one or two precise cuts in the next protein in the chain rather than fully digesting it. Each step amplifies the signal, ultimately producing a burst of the enzyme thrombin. Thrombin then clips fibrinogen, a soluble blood protein, into fibrin, which spontaneously assembles into the mesh framework of a blood clot. This entire process depends on controlled, limited proteolysis rather than the complete protein destruction seen inside cells.
Bacterial Cells
Bacteria lack proteasomes but use functionally similar ATP-dependent proteases to manage their protein turnover. The main players are ClpAP, ClpXP, HslUV, FtsH, and Lon. Like the proteasome, these bacterial proteases bury their cutting sites deep inside barrel-shaped structures, accessible only through narrow channels that exclude folded proteins. Bacteria tag proteins for destruction using exposed sequence tags on the protein’s surface or through adapter proteins that physically deliver substrates to the protease. One well-studied example is the ssrA tag, a short amino acid sequence added to incomplete proteins, which is recognized by multiple bacterial proteases.
What Happens When Proteolysis Fails
When any of these systems break down, proteins accumulate in forms the cell can’t handle. In neurodegenerative diseases, failed proteolysis contributes to the buildup of toxic protein aggregates. In Alzheimer’s disease, researchers have identified specific cleavage products of structural nerve cell proteins called neurofilaments that appear in the brain and can serve as biomarkers. In Parkinson’s disease, certain mutations in neurofilament genes cause the proteins to misfold and form inclusions inside neurons, collapsing the cell’s internal skeleton and leading to cell death. The sheer number of abnormal protein fragments these mutations produce, over 150,000 unique cleavage products identified in one study, hints at how profoundly disrupted proteolysis reshapes the protein landscape of affected cells.